Home> Products> dopaminergic receptors efficacy

{ "products": [ { "_id": "666be6b8aa93342004eef58f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 2 ", "description": "ROPINPRIME 2 \nRopinirole (2mg)\nIntroduction:\n\nRopinprime 2 is a medication containing Ropinirole, a potent dopamine agonist used primarily for treating Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 2mg, Ropinprime 2 is designed to effectively alleviate symptoms by mimicking dopamine's action in the brain, thus improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 2 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This action helps reduce motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 2 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 2 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 2mg dosage strength allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 2 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 2 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 2 therapy to ensure therapeutic efficacy and patient safety.\n\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/ropinprime-2-133629", "price": 135.0, "discountamount": 40.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "RLS", "1mg", "8mg", "life", "aids", "food", "brain", "Order", "EMAIL", "0.5mg", "water", "0.25mg", "action", "nausea", "bedtime", "disease", "tremors", "patients", "Benefits", "condition", "Parkinson", "stiffness", "Ropinirole", "likelihood", "medication", "information", "Introduction", "bradykinesia", "independence", "tolerability", "initial dose", "sterisonline", "sterispharma", "greater ease", "Key Features", "CALL/WHATSAPP", "sleep quality", "starting dose", "motor symptoms", "patient safety", "multiple doses", "Initial Dosage", "overall comfort", "treatment plans", "slowed movement", "symptom control", "patient response", "symptom severity", "daily activities", "clinical response", "Maintenance doses", "Regular monitoring", "dopamine receptors", "uncontrollable urge", "2mg dosage strength", "Ropinprime 2 therapy", "healthcare providers", "therapeutic efficacy", "Continued Monitoring", "dopaminergic activity", "overall motor function", "potential side effects", "potent dopamine agonist", "Improved Motor Function", "uncomfortable sensations", "flexible dosing regimens", "individual patient needs", "Administration Instructions", "Swallow Ropinprime 2 tablets", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1895, "imageuri": "https://productimages.withfloats.com/actual/667d15dbce74849f89cdd68a.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d15dbce74849f89cdd68a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:44:08.261Z", "updatedon": "2024-06-27T07:33:46.566Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-2-/1895", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 2 ", "category": "NEUROLOGY RANGE", "tags": [ "Ropinirole (2mg)", "ROPINPRIME 2", "ropinirole side effects", "ropinirole side effects: weight gain", "ropinirole side effects in elderly" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be5a070774b1f84f699ad", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 1 ", "description": "ROPINPRIME 1 \nRopinirole (1mg)\nIntroduction:\n\nRopinprime 1 contains Ropinirole, a potent dopamine agonist used primarily to treat Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 1mg, Ropinprime 1 is designed to alleviate symptoms by mimicking the action of dopamine in the brain, thereby improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 1 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This mechanism helps reduce the motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 1 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 1 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 1mg dosage strength provides flexibility in dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 1 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 1 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 1 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/ropinprime-1-133628", "price": 124.0, "discountamount": 37.2, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RLS", "day", "8mg", "life", "food", "EMAIL", "water", "0.5mg", "Order", "brain", "nausea", "action", "0.25mg", "bedtime", "disease", "tremors", "patients", "Benefits", "movement", "mechanism", "condition", "Parkinson", "stiffness", "medication", "likelihood", "Ropinirole", "flexibility", "information", "bradykinesia", "independence", "tolerability", "Introduction", "sterisonline", "initial dose", "sterispharma", "Key Features", "greater ease", "CALL/WHATSAPP", "starting dose", "sleep quality", "motor symptoms", "Initial Dosage", "multiple doses", "patient safety", "symptom control", "treatment plans", "dosing regimens", "Flexible Dosing", "overall comfort", "symptom severity", "patient response", "daily activities", "Maintenance doses", "clinical response", "dopamine receptors", "Regular monitoring", "1mg dosage strength", "uncontrollable urge", "Continued Monitoring", "therapeutic efficacy", "healthcare providers", "Ropinprime 1 therapy", "dopaminergic activity", "overall motor function", "potential side effects", "potent dopamine agonist", "Improved Motor Function", "individual patient needs", "uncomfortable sensations", "Administration Instructions", "Swallow Ropinprime 1 tablets", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1894, "imageuri": "https://productimages.withfloats.com/actual/666be5a4475de163fe91643d.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666be5a4475de163fe91643d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:39:28.983Z", "updatedon": "2024-06-26T07:04:00.123Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-1-/1894", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 1 ", "category": "NEUROLOGY RANGE", "tags": [ "ROPINPRIME 1", "ropinirole side effects in elderly", "ropinirole side effects", "ropinirole warnings" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be4714cb45413344ec323", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 0.5 ", "description": "ROPINPRIME 0.5 \nRopinirole (0.5mg)\nIntroduction:\n\nRopinprime 0.5 contains Ropinirole, a dopamine agonist used primarily for treating Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 0.5mg, Ropinprime 0.5 aims to alleviate symptoms by mimicking the action of dopamine in the brain, thus improving motor function and enhancing quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 0.5 acts as a dopamine agonist, directly stimulating dopamine receptors in the brain. This action helps reduce the motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 0.5 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 0.5 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 0.5mg dosage strength allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Ropinprime 0.5 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability.\nRestless Legs Syndrome:\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. Dosage may be adjusted according to patient response and symptom control.\nAdministration Instructions:\nSwallow Ropinprime 0.5 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 0.5 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/ropinprime-0-5-133627", "price": 60.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RLS", "aids", "life", "food", "Order", "water", "brain", "EMAIL", "0.25mg", "nausea", "action", "bedtime", "disease", "tremors", "patients", "Benefits", "stiffness", "condition", "Parkinson", "Ropinirole", "likelihood", "medication", "information", "Introduction", "initial dose", "independence", "greater ease", "tolerability", "Key Features", "sterispharma", "bradykinesia", "sterisonline", "CALL/WHATSAPP", "sleep quality", "starting dose", "patient safety", "motor symptoms", "Initial Dosage", "overall comfort", "treatment plans", "slowed movement", "symptom control", "dopamine agonist", "patient response", "daily activities", "symptom severity", "clinical response", "Regular monitoring", "dopamine receptors", "uncontrollable urge", "Continued Monitoring", "healthcare providers", "therapeutic efficacy", "0.5mg dosage strength", "dopaminergic activity", "Ropinprime 0.5 therapy", "overall motor function", "potential side effects", "Improved Motor Function", "individual patient needs", "uncomfortable sensations", "flexible dosing regimens", "Administration Instructions", "Restless Legs Syndrome Relief", "Swallow Ropinprime 0.5 tablets" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1893, "imageuri": "https://productimages.withfloats.com/actual/666be475844f2600246a0b63.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666be475844f2600246a0b63.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:34:25.708Z", "updatedon": "2024-06-26T07:04:57.853Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-0-5-/1893", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 0.5 ", "category": "NEUROLOGY RANGE", "tags": [ "ropinprime 0.5 mg tablet 10", "ropinprime 0.5 mg tablet uses", "ropin 0.5 injection", "ropinirole warnings", "ropinirole side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68e63e06f3481c1f16d3ae51", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tenofovir Alafenamide 25 mg", "description": "TELAVINCE AF 25 is primarily indicated for:\n\nHypertension (High Blood Pressure): Effectively helps in lowering elevated blood pressure.\n\nCardiovascular Risk Reduction: Supports heart health and reduces the risk of heart attack, stroke, and other complications related to high blood pressure.\n\nPatients requiring combination therapy: Ideal for individuals who need more than one antihypertensive agent for optimal blood pressure control.\n\nMechanism of Action:\n\nTELAVINCE AF 25 combines two mechanisms for effective blood pressure management:\n\nTelmisartan: Blocks angiotensin II receptors, preventing blood vessel constriction and thereby reducing blood pressure.\n\n[AF Component, e.g., Amlodipine]: Relaxes blood vessels by inhibiting calcium entry into vascular smooth muscles, improving blood flow and reducing strain on the heart.\n\nThis dual-action combination provides better efficacy than single-drug therapy while maintaining a favorable safety profile.\n\nDosage and Administration:\n\nRecommended Dose: As prescribed by a healthcare professional, typically one tablet daily.\n\nRoute: Oral, with water.\n\nTiming: Can be taken with or without food, preferably at the same time each day.\n\nAdjustment: Dose may be adjusted based on individual response and tolerability.\n\nImportant: Always follow your doctor’s instructions. Do not change the dose or stop medication without medical advice.\n\nKey Benefits of TELAVINCE AF 25:\n\nEffective blood pressure control with dual-action therapy.\n\nReduces the risk of cardiovascular complications associated with hypertension.\n\nConvenient once-daily dosing for better patient adherence.\n\nWell-tolerated with minimal side effects.\n\nSuitable for long-term use under medical supervision.\n\nSafety and Precautions:\n\nInform your doctor if you have kidney disease, liver disease, or heart failure.\n\nPregnant or breastfeeding women should use only if recommended by a physician.\n\nAvoid excessive use of potassium-containing salt substitutes.\n\nRegular monitoring of blood pressure and kidney function is recommended.\n\nDo not combine with other angiotensin receptor blockers (ARBs) unless prescribed.\n\nPossible Side Effects:\n\nWhile generally well-tolerated, some patients may experience:\n\nDizziness or lightheadedness\n\nFatigue or weakness\n\nMild swelling of ankles or feet\n\nNausea or headache\n\nSeek immediate medical attention if you experience:\n\nSevere allergic reactions\n\nSwelling of face, lips, or throat\n\nDifficulty breathing\n\nStorage Instructions:\n\nStore in a cool, dry place away from sunlight.\n\nKeep out of reach of children and pets.\n\nDo not use after the expiry date mentioned on the package.\n\nWhy Choose TELAVINCE AF 25:\n\nDeveloped by Steris Healthcare Pvt. Ltd, a trusted pharmaceutical company.\n\nEnsures quality, safety, and efficacy in every tablet.\n\nDesigned for patient convenience with once-daily dosing.\n\nBacked by clinical research for effective hypertension management.\n\nDisclaimer:\n\nThe information provided here is for educational purposes only. TELAVINCE AF 25 should be used only under medical supervision. Consult your healthcare provider for personalized advice. Side effects may vary from person to person.\n\n", "price": 1566.0, "discountamount": 470.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2184, "imageuri": "https://productimages.withfloats.com/actual/68e63e0d931b4d6a7310ae2a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68e63e0d931b4d6a7310ae2a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-08T10:33:42.289Z", "updatedon": "2025-10-08T10:35:29.464Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tenofovir-alafenamide-25-mg/2184", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris Healthcare Pvt. Ltd.", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68e63c17e7475f0f453d4b6e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tenofovir (300mg), Emtricitabine (200mg) & Efavirenz (600 mg)", "description": "TELAVINCE EM is primarily indicated for the management of:\n\nHypertension (High Blood Pressure): Helps in reducing elevated blood pressure effectively.\n\nCardiovascular Risk Reduction: Supports heart health and reduces the risk of stroke, heart attack, and related complications.\n\nPatients requiring combination therapy: Suitable for individuals who need more than one antihypertensive for better blood pressure control.\n\nMechanism of Action:\n\nTELAVINCE EM works through a dual mechanism to control blood pressure:\n\nTelmisartan: Blocks angiotensin II receptors, preventing blood vessel constriction and reducing blood pressure.\n\n[EM Component, e.g., Amlodipine]: Relaxes blood vessels by inhibiting calcium entry into vascular smooth muscles, improving blood flow and reducing strain on the heart.\n\nThe combination ensures better efficacy than monotherapy while maintaining a favorable safety profile.\n\nDosage and Administration:\n\nRecommended Dose: As prescribed by a healthcare professional, typically one tablet daily.\n\nRoute: Oral administration with water.\n\nTiming: Can be taken with or without food, preferably at the same time each day.\n\nAdjustment: Dose may be modified based on individual response and tolerability.\n\nImportant: Always follow your doctor’s instructions. Do not alter the dose or stop medication without medical advice.\n\nKey Benefits of TELAVINCE EM:\n\nEffective blood pressure control with dual-action therapy.\n\nReduces risk of cardiovascular events associated with hypertension.\n\nConvenient once-daily dosing improves patient compliance.\n\nWell-tolerated with a low incidence of side effects.\n\nSuitable for long-term use under medical supervision.\n\nSafety and Precautions:\n\nInform your doctor if you have kidney disease, liver disease, or heart failure.\n\nPregnant or breastfeeding women should avoid use unless advised by a physician.\n\nAvoid excessive salt substitutes containing potassium.\n\nRegular blood pressure and kidney function monitoring is recommended.\n\nDo not use in combination with other angiotensin receptor blockers (ARBs) unless prescribed.\n\nPossible Side Effects:\n\nAlthough TELAVINCE EM is generally well-tolerated, some patients may experience:\n\nDizziness or lightheadedness\n\nFatigue or weakness\n\nMild swelling in ankles or feet\n\nNausea or headache\n\nSeek immediate medical attention if you experience severe side effects such as difficulty breathing, swelling of face or throat, or severe allergic reactions.\n\nStorage Instructions:\n\nStore in a cool, dry place away from direct sunlight.\n\nKeep out of reach of children and pets.\n\nDo not use after the expiry date mentioned on the package.\n\nWhy Choose TELAVINCE EM:\n\nDeveloped by Steris Healthcare Pvt. Ltd, a trusted name in pharmaceutical excellence.\n\nEnsures quality, safety, and efficacy in every tablet.\n\nDesigned for optimal patient compliance with convenient dosing.\n\nBacked by clinical research for managing hypertension effectively.\n\nDisclaimer:\n\nThe information provided here is intended for educational purposes only. TELAVINCE EM should be used only under medical supervision. Consult your healthcare provider for personalized advice. Side effects may vary from person to person.", "price": 4715.0, "discountamount": 1415.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2183, "imageuri": "https://productimages.withfloats.com/actual/68e63c1a4302b5c8207e2858.png", "tileimageuri": "https://productimages.withfloats.com/tile/68e63c1a4302b5c8207e2858.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-08T10:25:27.075Z", "updatedon": "2025-10-08T10:36:46.57Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tenofovir-300mg-emtricitabine-200mg-efavirenz-600-mg-/2183", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris Healthcare Pvt. Ltd.", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6891f29bfb7044dfb2d43adf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MAGRAL 160", "description": "MAGRAL 160 is a pharmaceutical medication containing megestrol acetate 160 mg, a synthetic progestin known for its potent antineoplastic and appetite-stimulating properties. This drug is primarily prescribed to manage significant health challenges such as unexplained weight loss, anorexia, and cachexia, especially in patients suffering from chronic conditions like cancer or AIDS. Additionally, megestrol acetate functions as a hormone therapy agent employed in the treatment of certain hormone-sensitive malignancies. Its dual action both supports tumor management and improves patients' nutritional status by stimulating appetite and promoting weight gain, thereby enhancing overall quality of life. The drug is regarded as a crucial option in oncology and palliative care for managing complex conditions related to hormone-dependent cancers and severe wasting syndromes.\n\nWhat is MAGRAL 160?\nMAGRAL 160 is an oral medication formulated with megestrol acetate 160 mg, a synthetic progestin hormone derivative. It works primarily by modulating hormone receptors and altering hormone levels that influence the growth of hormone-responsive tumors such as breast and endometrial cancers. Apart from its antineoplastic action, it stimulates appetite by acting on the hypothalamic centers responsible for hunger, helping patients suffering from severe weight loss regain a healthy appetite and weight.\n\nUses of MAGRAL 160\n\nTo treat hormone-dependent cancers, specifically advanced breast cancer and endometrial cancer.\n\nTo stimulate appetite and promote weight gain in patients experiencing anorexia, cachexia, or unexplained severe weight loss related to chronic illnesses like cancer or AIDS.\n\nTo manage wasting syndromes that lead to malnutrition and significant weight loss.\n\nTo serve as an antineoplastic agent in hormone-sensitive malignancies.\n\nIn short, MAGRAL 160 is primarily used to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy.\n\nSide Effects of MAGRAL 160\n\nWeight gain (often desirable but can be excessive)\n\nFluid retention and edema (swelling)\n\nNausea and vomiting\n\nDiarrhea or constipation\n\nVaginal bleeding or spotting in women\n\nFatigue, weakness, and insomnia\n\nHeadache and dizziness\n\nIncreased risk of blood clots (deep vein thrombosis or pulmonary embolism)\n\nHormonal imbalances, such as decreased sex hormone levels, which can lead to sexual dysfunction or bone density loss\n\nAllergic reactions including rash or itching\n\nPatients should report severe or unusual symptoms, especially signs of blood clots such as limb swelling, chest pain, or sudden shortness of breath, immediately to their healthcare provider.\n\nPrecautions before Using MAGRAL 160\n\nInform your doctor if you are pregnant, breastfeeding, or planning to conceive as MAGRAL 160 is contraindicated in pregnancy.\n\nDisclose any history of blood clots, cardiovascular diseases, liver or kidney impairment.\n\nPatients with diabetes should monitor blood sugar closely as megestrol acetate may cause hyperglycemia.\n\nAvoid sudden discontinuation without medical advice to prevent potential hormonal withdrawal effects.\n\nRegular monitoring is required, including hormone levels and blood tests, to assess efficacy and safety during treatment.\n\nUse cautiously in patients at risk for deep vein thrombosis or pulmonary embolism due to increased clotting risks.\n\nDrug Interactions: What Drugs Interact with MAGRAL 160?\n\nCYP3A4 enzyme inducers (e.g., rifampin, phenytoin) may reduce the effectiveness of megestrol acetate by increasing its metabolism.\n\nConcurrent use with blood thinners (anticoagulants) requires careful monitoring as MAGRAL 160 might influence clotting parameters.\n\nCombining with drugs that affect hormonal pathways, such as other hormonal therapies or corticosteroids, may alter treatment outcomes.\n\nInteractions with diabetes medications might necessitate dose adjustment due to potential effects on blood sugar control.\n\nCareful medical supervision is necessary when used with immunosuppressants or other chemotherapy agents to avoid additive side effects or altered drug levels.\n\nConclusion\nMAGRAL 160, containing megestrol acetate 160 mg, is a clinically validated medication widely used to manage complex conditions such as hormone-dependent cancers as well as severe weight loss due to anorexia and cachexia. Its unique ability to act both as an antineoplastic agent and an appetite stimulant makes it invaluable in improving patient outcomes, nutritional status, and overall quality of life. Patients prescribed MAGRAL 160 should adhere strictly to their healthcare provider’s instructions and report any adverse effects promptly. This medication should always be used under medical supervision to ensure optimal benefits and minimize risks.", "price": 810.0, "discountamount": 243.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2156, "imageuri": "https://productimages.withfloats.com/actual/6891f2a0115b51057b971998.png", "tileimageuri": "https://productimages.withfloats.com/tile/6891f2a0115b51057b971998.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-05T12:01:31.195Z", "updatedon": "2025-08-05T12:01:31.195Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/magral-160/2156", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "megestrol acetate 160 mg", "category": "Gynaecology", "tags": [ "megestrol acetate 160 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "686fb2fa7b16001ae8bc7d90", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIMAPEXOLE 0.25", "description": "PIMAPEXOLE 0.25 is a prescription medication that contains Pramipexole 0.25 mg, a dopamine agonist used for the treatment of Parkinson's disease and Restless Leg Syndrome (RLS). This medication works by stimulating dopamine receptors in the brain, helping to restore balance in motor function and reduce the symptoms associated with these neurological conditions.\n\nWhat is PIMAPEXOLE 0.25?\nPIMAPEXOLE 0.25 is a dopamine receptor stimulant that mimics the action of dopamine, a chemical messenger involved in movement and coordination. It is primarily used to relieve the motor symptoms of Parkinson’s disease such as tremors, stiffness, and slowness of movement. It is also effective in treating Restless Leg Syndrome by reducing the uncomfortable sensations and the irresistible urge to move the legs.\n\nUses of PIMAPEXOLE 0.25\nParkinson’s Disease: Helps reduce motor symptoms by compensating for the brain's reduced dopamine levels.\n\nRestless Leg Syndrome (RLS): Reduces discomfort and the need to move the legs, especially during periods of rest or sleep.\n\nHow PIMAPEXOLE 0.25 Works\nPramipexole acts by directly stimulating dopamine receptors in the brain, especially in areas responsible for body movement. Unlike levodopa, which gets converted into dopamine, pramipexole bypasses this process and directly activates the necessary receptors, offering sustained symptom control.\n\nSide Effects of PIMAPEXOLE 0.25\nCommon side effects may include:\n\nNausea\n\nDizziness\n\nFatigue\n\nInsomnia\n\nHallucinations\n\nLow blood pressure (especially when standing)\n\nSerious side effects may include compulsive behaviors, heart problems, and sudden sleep episodes. Report any unusual behavior or symptoms to your doctor promptly.\n\nPrecautions Before Using PIMAPEXOLE 0.25\nInform your doctor if you have heart disease, kidney problems, or mental health issues.\n\nAvoid driving or operating machinery if you feel drowsy.\n\nUse cautiously in elderly patients, as they may be more prone to hallucinations or confusion.\n\nLet your doctor know if you’re pregnant, planning to become pregnant, or breastfeeding.\n\nAvoid alcohol consumption while taking this medication, as it may increase drowsiness or dizziness.\n\nDrug Interactions: What Drugs Interact with PIMAPEXOLE 0.25?\nPIMAPEXOLE 0.25 can interact with several medications, such as:\n\nAntipsychotics (e.g., haloperidol, risperidone) – may reduce the effectiveness of pramipexole.\n\nSedatives or sleeping pills – may increase drowsiness.\n\nCimetidine – can increase pramipexole levels in the body.\n\nLevodopa or other dopaminergic drugs – may enhance the risk of side effects such as hallucinations or involuntary movements.\n\nAlways consult your healthcare provider before starting, stopping, or combining PIMAPEXOLE 0.25 with any other medication.\n\nConclusion\nPIMAPEXOLE 0.25 (Pramipexole 0.25 mg tablet) offers effective symptomatic relief for individuals suffering from Parkinson’s disease and Restless Leg Syndrome. Its targeted action on dopamine receptors helps manage symptoms and improve quality of life. Regular follow-ups and medical supervision are essential to ensure safety and optimal results.", "price": 65.0, "discountamount": 20.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2144, "imageuri": "https://productimages.withfloats.com/actual/686fb309d34d0d0ece846a89.png", "tileimageuri": "https://productimages.withfloats.com/tile/686fb309d34d0d0ece846a89.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-10T12:32:58.311Z", "updatedon": "2025-07-10T12:33:52.588Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pimapexole-0-25/2144", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "pramipexole 0.25 mg tablet", "category": "NEUROLOGY RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "686e5df44c01bda1661052f0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ALFUGEM T 2.5/10", "description": "ALFUGEM T 2.5/10 is a scientifically formulated dual-action oral tablet that combines Alfuzosin 2.5 mg and Tadalafil 10 mg. This unique combination is primarily used for the treatment of benign prostatic hyperplasia (BPH) and erectile dysfunction (ED) in men. By blending a selective alpha-blocker (Alfuzosin) with a phosphodiesterase-5 (PDE5) inhibitor (Tadalafil), ALFUGEM T 2.5/10 offers an effective solution for patients who suffer from both urological conditions.\n\nThe combination of alfuzosin and tadalafil has been shown to have an additive relaxant effect on human detrusor and prostatic tissues in vitro, enhancing urinary flow and improving sexual function.\n\nWhat is ALFUGEM T 2.5/10?\nALFUGEM T 2.5/10 is a fixed-dose combination tablet that contains two active ingredients:\n\nAlfuzosin (2.5 mg) – an alpha-1 adrenergic receptor blocker that relaxes the muscles in the prostate and bladder neck.\n\nTadalafil (10 mg) – a PDE5 inhibitor that increases blood flow to the penis and also helps relax the smooth muscles in the prostate and bladder.\n\nTogether, they help relieve lower urinary tract symptoms (LUTS) associated with BPH and improve erectile function in men.\n\nUses of ALFUGEM T 2.5/10:\nTreatment of Benign Prostatic Hyperplasia (BPH)\n\nRelief of lower urinary tract symptoms (LUTS) such as weak stream, urgency, and incomplete bladder emptying\n\nManagement of erectile dysfunction (ED) in men\n\nMay be beneficial for patients with both BPH and ED as a once-daily treatment\n\nHow Does ALFUGEM T 2.5/10 Work?\nAlfuzosin works by blocking alpha-1 receptors in the prostate and bladder, leading to relaxation of smooth muscle and improved urine flow.\n\nTadalafil enhances nitric oxide activity, leading to vasodilation in the penile tissues and also relaxes the lower urinary tract muscles.\n\nThe additive relaxant effect of this combination on the prostate and bladder tissues helps improve both urinary and sexual symptoms.\n\nSide Effects of ALFUGEM T 2.5/10:\nLike all medications, ALFUGEM T 2.5/10 may cause some side effects. Common side effects include:\n\nDizziness or lightheadedness\n\nHeadache\n\nBack pain or muscle aches\n\nNasal congestion\n\nIndigestion\n\nFlushing\n\nLow blood pressure (hypotension) in some cases\n\nRare but serious side effects may include:\n\nFainting or severe dizziness\n\nPriapism (prolonged or painful erection)\n\nVision changes or sudden vision loss\n\nChest pain or irregular heartbeat\n\nPrecautions Before Using ALFUGEM T 2.5/10:\nConsult your doctor before use if you have a history of heart disease, liver/kidney problems, or hypotension.\n\nAvoid activities like driving or operating machinery if you feel dizzy after taking the tablet.\n\nDo not take with other PDE5 inhibitors or alpha-blockers unless prescribed.\n\nLimit alcohol intake, as it can increase the risk of dizziness or low blood pressure.\n\nNot recommended for use in women or children.\n\nDrug Interactions – What Drugs Interact with ALFUGEM T 2.5/10?\nCertain drugs may interact with ALFUGEM T 2.5/10 and affect its effectiveness or increase the risk of side effects:\n\nAvoid or use with caution:\n\nNitrates (e.g., nitroglycerin) – can cause dangerous drops in blood pressure\n\nOther alpha-blockers – increased risk of hypotension\n\nAntifungals (e.g., ketoconazole, itraconazole)\n\nHIV protease inhibitors (e.g., ritonavir)\n\nAntibiotics (e.g., erythromycin, clarithromycin)\n\nBlood pressure medications – may enhance hypotensive effect\n\nGrapefruit juice – can alter the drug metabolism\n\nAlways inform your doctor about all the medications and supplements you are taking.\n\nConclusion:\nALFUGEM T 2.5/10 offers a comprehensive dual-action approach to managing two common male conditions – BPH and ED. With the clinically proven benefits of alfuzosin and tadalafil, this medication not only improves urinary flow and relieves prostate-related discomfort but also enhances sexual performance. Its synergistic relaxant effect on the bladder, prostate, and penile tissues makes it an ideal solution for men looking for convenience, efficacy, and improved quality of life.\n\nAlways follow your healthcare provider’s instructions for safe and effective use.", "price": 310.0, "discountamount": 93.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2143, "imageuri": "https://productimages.withfloats.com/actual/686e5df9e9241987c803df61.png", "tileimageuri": "https://productimages.withfloats.com/tile/686e5df9e9241987c803df61.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-09T12:17:56.999Z", "updatedon": "2025-07-09T12:17:56.999Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/alfugem-t-2-5-10/2143", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "alfuzosin and tadalafil", "category": "UROLOGYRANGE", "tags": [ "alfuzosin and tadalafil" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "684c06eef063f1699d39f96b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "BISALATIN M KID", "description": "BISALATIN M KID is a specially formulated oral suspension for children, combining Bilastine 10mg and Montelukast 4mg, two potent agents known for their efficacy in treating allergic rhinitis, seasonal allergies, and mild to moderate asthma symptoms. Developed with a palatable taste and child-friendly formulation, BISALATIN M KID provides fast, effective relief from sneezing, runny nose, nasal congestion, itchy eyes, and breathing difficulties—ensuring your little one stays healthy and active.\n\nKey Ingredients:\nBilastine: A second-generation non-sedating antihistamine that blocks the H1 receptor to treat allergic symptoms like sneezing, itching, watery eyes, and rashes.\n\nMontelukast: A leukotriene receptor antagonist that helps reduce inflammation in the airways, preventing wheezing and shortness of breath in conditions like asthma and allergic rhinitis.\n\nKey Benefits:\nDual-action relief from both nasal and bronchial allergic symptoms.\n\nEffective management of asthma symptoms and seasonal allergic rhinitis.\n\nNon-sedative and safe for daytime use—does not cause drowsiness in most children.\n\nEasy-to-administer oral liquid form with a pleasant taste for kids.\n\nReduces the need for frequent use of inhalers or nasal sprays.\n\nHow Does It Work?\nBilastine works by blocking histamine H1 receptors, thereby preventing histamine—a chemical your body makes during allergic reactions—from causing symptoms like itching, swelling, and congestion. Montelukast blocks leukotrienes, substances that cause narrowing and swelling of airways in the lungs. Together, they provide comprehensive relief from both upper and lower respiratory allergic symptoms.\n\nDirections for Use:\nShake the bottle well before use.\n\nAdminister the prescribed dosage using the included measuring cup or dropper.\n\nCan be taken with or without food.\n\nAlways follow your pediatrician’s dosage and timing recommendations.\n\nPossible Side Effects:\nBISALATIN M KID is generally well-tolerated. However, some children may experience:\n\nMild drowsiness\n\nAbdominal discomfort\n\nHeadache\n\nDry mouth\n\nBehavioral changes (rare, usually with montelukast)\n\nNote: If any side effects persist or worsen, consult your doctor immediately.\n\nConclusion:\nBISALATIN M KID is a trusted pediatric formulation that ensures dual-action protection against allergy and asthma symptoms, enhancing your child’s comfort and quality of life. Recommended by healthcare professionals, it’s the smart choice for complete allergy management in children.", "price": 113.0, "discountamount": 34.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "itching swelling", "nasal sprays", "smart choice", "healthcare professionals", "life recommended", "childs comfort", "worsen consult", "montelukast note", "generally welltolerated", "timing recommendations", "pediatricians dosage", "prescribed dosage", "body makes", "kids reduces", "pleasant taste", "daytime usedoes", "rashes montelukast", "stays healthy", "breathing difficultiesensuring", "palatable taste", "potent agents", "montelukast 4mg", "h1 receptor", "asthma symptoms", "asthma symptoms enhancing", "complete allergy management", "airways preventing wheezing", "side effects bisalatin", "childfriendly formulation bisalatin", "leukotriene receptor antagonist", "treat allergic symptoms", "ensures dualaction protection", "trusted pediatric formulation", "side effects persist", "included measuring cup", "provide comprehensive relief", "preventing histaminea chemical", "work bilastine works", "helps reduce inflammation", "secondgeneration nonsedating antihistamine", "fast effective relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2134, "imageuri": "https://productimages.withfloats.com/actual/684c06f1255b74d4876bb6a1.png", "tileimageuri": "https://productimages.withfloats.com/tile/684c06f1255b74d4876bb6a1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-13T11:09:34.876Z", "updatedon": "2025-06-13T11:13:28.683Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/bisalatin-m-kid/2134", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Bilastine & Montelukast Oral Suspension", "category": "PEDIATRICS", "tags": [ "Bilastine and montelukast syrup dose for child", "Bilastine montelukast oral suspension uses in hindi", "Bilastine and Montelukast side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }